BrainStorm Cell Therapeutics to Provide Update on NurOwn Program

A conference call and webcast will be held Tomorrow, April 9, at 8:00 a.m. Eastern Time
NEW YORK, April 8, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. , a leading developer of cellular...

Related Keywords

California ,United States ,Michael Wood ,Chaim Lebovits ,Stacy Lindborg ,Bob Dagher ,Prnewswire Brainstorm Cell Therapeutics Inc ,European Medicines Agency ,National Ms Society ,Nasdaq ,Drug Administration ,Brainstorm Cell Therapeutics Inc ,California Institute For Regenerative Medicine ,Storm Cell Therapeutics ,Chief Executive Officer ,Co Chief Executive Officer ,Chief Development Officer ,Replay Number ,Orphan Drug ,California Institute ,Regenerative Medicine ,Regarding Forward Looking Statements ,Special Protocol Assessment ,